Rubius Therapeutics Inc (RUBY)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-02-27 | 2023-02-24 | S Sale |
CEO and President Officer |
10,385
-100.0%
0.13USD 1,323 |
10,385 -100.0% | 0.13 | USD 1,323 | |
| 2023-02-01 | 2023-02-01 | S Sale | Non-Executive Director |
8,448
-11.3%
0.25USD 2,112 |
8,448 -11.3% | 0.25 | USD 2,112 | |
| 2023-02-01 | 2023-02-01 | S Sale |
CEO and President Officer |
3,878
-27.2%
0.25USD 970 |
3,878 -27.2% | 0.25 | USD 970 | |
| 2023-01-31 | 2023-01-31 | S Sale |
Chief Scientific Officer Officer |
2,593
-12.4%
0.24USD 622 |
2,593 -12.4% | 0.24 | USD 622 | |
| 2023-01-31 | 2023-01-31 | S Sale | Non-Executive Director |
7,240
-8.9%
0.24USD 1,745 |
7,240 -8.9% | 0.24 | USD 1,745 | |
| 2022-08-12 | 2022-08-10 | S Sale |
Chief Operating Officer Officer |
5,737
-45.9%
0.80USD 4,590 |
5,737 -45.9% | 0.80 | USD 4,590 | |
| 2022-04-22 | 2022-04-21 | B Purchase | Non-Executive Director |
30,000
+0.6%
1.44USD 43,329 |
30,000 +0.6% | 1.44 | USD 43,329 | |
| 2022-02-01 | 2022-02-01 | S Sale |
Chief Scientific Officer Officer |
2,517
-33.8%
6.57USD 16,544 |
2,517 -33.8% | 6.57 | USD 16,544 | |
| 2022-02-01 | 2022-02-01 | S Sale |
CEO and President Executive Director |
6,730
-15.9%
6.57USD 44,236 |
6,730 -15.9% | 6.57 | USD 44,236 | |
| 2022-02-01 | 2022-02-01 | S Sale |
CLO & Corp. Secretary Officer |
2,732
-33.8%
6.57USD 17,957 |
2,732 -33.8% | 6.57 | USD 17,957 | |
| 2021-03-23 | 2021-03-19 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
70,000
+2.7%
29.00USD 2,030,000 |
70,000 +2.7% | 29.00 | USD 2,030,000 | |
| 2021-03-23 | 2021-03-19 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
70,000
+1.2%
29.00USD 2,030,000 |
70,000 +1.2% | 29.00 | USD 2,030,000 | |
| 2021-03-23 | 2021-03-19 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
70,000
+0.5%
29.00USD 2,030,000 |
70,000 +0.5% | 29.00 | USD 2,030,000 | |
| 2021-03-15 | 2021-03-15 | PS Planned sale |
CLO & Corp. Secretary Officer |
25,000
-100.0%
20.24USD 505,965 |
25,000 -100.0% | 20.24 | USD 505,965 | |
| 2021-02-16 | 2021-02-11 | PS Planned sale | Non-Executive Director |
26,704
-0.6%
14.93USD 398,560 |
26,704 -0.6% | 14.93 | USD 398,560 | |
| 2021-02-10 | 2021-02-10 | PS Planned sale | Non-Executive Director |
7,404
-0.2%
14.79USD 109,525 |
7,404 -0.2% | 14.79 | USD 109,525 | |
| 2021-02-10 | 2021-02-09 | PS Planned sale | Non-Executive Director |
2,100
-0.0%
14.83USD 31,146 |
2,100 -0.0% | 14.83 | USD 31,146 | |
| 2021-02-10 | 2021-02-08 | PS Planned sale | Non-Executive Director |
89,233
-1.9%
14.88USD 1,328,117 |
89,233 -1.9% | 14.88 | USD 1,328,117 | |
| 2020-04-24 | 2020-04-22 | B Purchase |
Chief Medical Officer Officer |
19,000
+inf%
5.52USD 104,814 |
19,000 +inf% | 5.52 | USD 104,814 | |
| 2020-04-15 | 2020-04-14 | B Purchase |
CEO and President Executive Director |
21,000
+inf%
4.70USD 98,694 |
21,000 +inf% | 4.70 | USD 98,694 |